相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Clinical management of cannabis withdrawal
Jason P. Connor et al.
ADDICTION (2022)
Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial
Danielle McCartney et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2022)
Determining the magnitude and duration of acute Δ9-tetrahydrocannabinol (Δ9-THC)-induced driving and cognitive impairment: A systematic and meta-analytic review
Danielle McCartney et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2021)
Cannabidiol for Rapid Eye Movement Sleep Behavior Disorder
Carlos M. O. de Almeida et al.
MOVEMENT DISORDERS (2021)
Is medical cannabis safe for my patients? A practical review of cannabis safety considerations
Caroline A. MacCallum et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)
Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo
Jennifer H. Walsh et al.
SLEEP (2021)
A primer on medicinal cannabis safety and potential adverse effects
Jonathon C Arnold
Australian Journal of General Practice (2021)
Treating insomnia symptoms with medicinal cannabis: a randomized, crossover trial of the efficacy of a cannabinoid medicine compared with placebo
Jennifer H. Walsh et al.
SLEEP (2021)
Blunted highs: Pharmacodynamic and behavioral models of cannabis tolerance
J. G. Ramaekers et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Impact of circadian rhythmicity and sleep restriction on circulating endocannabinoid (eCB) N-arachidonoylethanolamine (anandamide)
Erin C. Hanlon
PSYCHONEUROENDOCRINOLOGY (2020)
Validating lane drifts as a predictive measure of drug or sleepiness induced driving impairment
F. R. J. Vinckenbosch et al.
PSYCHOPHARMACOLOGY (2020)
More evidence of cannabis efficacy in restless legs syndrome
Imad Ghorayeb
SLEEP AND BREATHING (2020)
CSF Levels of the Endocannabinoid Anandamide are Reduced in Patients with Untreated Narcolepsy Type 1: A Pilot Study
Andrea Romigi et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2020)
Inhalation Toxicology of Vaping Products and Implications for Pulmonary Health
Hussein Traboulsi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cannabinoid therapies in the management of sleep disorders: A systematic review of preclinical and clinical studies
Anastasia S. Suraev et al.
SLEEP MEDICINE REVIEWS (2020)
Cannabidiol (CBD) and Delta(9)-tetrahydrocannabinol (THC) for chronic insomnia disorder ('CANSLEEP' trial): protocol for a randomised, placebo-controlled, double-blinded, proof-of-concept trial
Anastasia Suraev et al.
BMJ OPEN (2020)
Cannabinoids, Endocannabinoids and Sleep
Andrew J. Kesner et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2020)
Cannabinoids in the Treatment of Insomnia Disorder: A Systematic Review and Meta-Analysis
Chiranth Bhagavan et al.
CNS DRUGS (2020)
Effect of Cannabidiol and Δ9-Tetrahydrocannabinol on Driving Performance A Randomized Clinical Trial
Thomas R. Arkell et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Prescribing medicinal cannabis
Jonathon C. Arnold et al.
AUSTRALIAN PRESCRIBER (2020)
Medical cannabis use in the Australian community following introduction of legal access: the 2018-2019 Online Cross-Sectional Cannabis as Medicine Survey (CAMS-18)
Nicholas Lintzeris et al.
HARM REDUCTION JOURNAL (2020)
A Phase 1, Open-Label, Parallel-Group, Single-Dose Trial of the Pharmacokinetics and Safety of Cannabidiol (CBD) in Subjects With Mild to Severe Hepatic Impairment
Lesley Taylor et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Insomnia as a predictor of mental disorders: A systematic review and meta-analysis
Elisabeth Hertenstein et al.
SLEEP MEDICINE REVIEWS (2019)
The Use of Cannabinoids for Sleep: A Critical Review on Clinical Trials
Nirushi Kuhathasan et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2019)
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
Thomas R. Arkell et al.
PSYCHOPHARMACOLOGY (2019)
Cannabidiol Partially Blocks the Excessive Sleepiness in Hypocretin-deficient Rats: Preliminary Data
Eric Murillo-Rodriguez et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2019)
Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea
David W. Carley et al.
SLEEP (2018)
Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea
David W. Carley et al.
SLEEP (2018)
Cannabis and psychosis: what do we know and what should we do?
Marco Colizzi et al.
BRITISH JOURNAL OF PSYCHIATRY (2018)
Practical considerations in medical cannabis administration and dosing
Caroline A. MacCallum et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report
Donald I. Abrams
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2018)
Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System
Shenglong Zou et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Increasing access to and utilization of cognitive behavioral therapy for insomnia (CBT-I): a narrative review
Erin Koffel et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2018)
No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
Ila M. P. Linares et al.
FRONTIERS IN PHARMACOLOGY (2018)
The Residual Medium and Long-term Cognitive Effects of Benzodiazepine Use: An Updated Meta-analysis
Simon F. Crowe et al.
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY (2018)
An interaction between warfarin and cannabidiol, a case report
Leslie Grayson et al.
EPILEPSY & BEHAVIOR CASE REPORTS (2018)
Routes of administration for cannabis use - basic prevalence and related health outcomes: A scoping review and synthesis
Cayley Russell et al.
INTERNATIONAL JOURNAL OF DRUG POLICY (2018)
Prevalence and comorbidity of sleep conditions in Australian adults: 2016 Sleep Health Foundation national survey
Sarah L. Appleton et al.
SLEEP HEALTH (2018)
Labeling Accuracy of Cannabidiol Extracts Sold Online
Marcel O. Bonn-Miller et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Substitution of medical cannabis for pharmaceutical agents for pain, anxiety, and sleep
Brian J. Piper et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2017)
Zombie Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York
Axel J. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Cannabis for restless legs syndrome: a report of six patients
Thomas Megelin et al.
SLEEP MEDICINE (2017)
Cannabis, Cannabinoids, and Sleep: a Review of the Literature
Kimberly A. Babson et al.
CURRENT PSYCHIATRY REPORTS (2017)
Insomnia and Risk of Cardiovascular Disease
Sogol Javaheri et al.
CHEST (2017)
Cannabis withdrawal and sleep: A systematic review of human studies
Peter Gates et al.
SUBSTANCE ABUSE (2016)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
Cannabis effects on driving longitudinal control with and without alcohol
Rebecca L. Hartman et al.
JOURNAL OF APPLIED TOXICOLOGY (2016)
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol
Erin C. Hanlon et al.
SLEEP (2016)
Sleep Restriction Enhances the Daily Rhythm of Circulating Levels of Endocannabinoid 2-Arachidonoylglycerol
Erin C. Hanlon et al.
SLEEP (2016)
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy
Alexandra L. Geffrey et al.
EPILEPSIA (2015)
Cannabinoids for Medical Use A Systematic Review and Meta-analysis
Penny F. Whiting et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Circadian Rhythm of Circulating Levels of the Endocannabinoid 2-Arachidonoylglycerol
E. C. Hanlon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case series
M. H. N. Chagas et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2014)
Impact of Dronabinol on Quantitative Electroencephalogram (qEEG) Measures of Sleep in Obstructive Sleep Apnea Syndrome
Sarah S. Farabi et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2014)
The effects of cannabinoid administration on sleep: a systematic review of human studies
Peter J. Gates et al.
SLEEP MEDICINE REVIEWS (2014)
Exercise increases plasma THC concentrations in regular cannabis users
Alexander Wong et al.
DRUG AND ALCOHOL DEPENDENCE (2013)
Proof of Concept Trial of Dronabinol in Obstructive Sleep Apnea
Bharati Prasad et al.
Frontiers in Psychiatry (2013)
Cannabidiol, a Major Phytocannabinoid, As a Potent Atypical Inhibitor for CYP2D6
Satoshi Yamaori et al.
DRUG METABOLISM AND DISPOSITION (2011)
Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine
Philip Robson
EXPERT OPINION ON DRUG SAFETY (2011)
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Mark A. Ware et al.
ANESTHESIA AND ANALGESIA (2010)
Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes
Satoshi Yamaori et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Endocannabinoid signalling: has it got rhythm?
Linda K. Vaughn et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Pharmacology of vagal afferent influences on disordered breathing during sleep
David W. Carley et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2008)
Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy and marijuana
Thomas Schierenbeck et al.
SLEEP MEDICINE REVIEWS (2008)
Cannabis, pain, and sleep: Lessons from therapeutic clinical trials of Sativex((R)), a cannabis-based medicine
Ethan B. Russo et al.
CHEMISTRY & BIODIVERSITY (2007)
The endocannabinoid system and its therapeutic exploitation
V Di Marzo et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Effect of Δ-9-tetrahydrocannabinol and cannabidiol on nocturnal sleep and early-morning behavior in young adults
AN Nicholson et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2004)
Sleep modulates cannabinoid receptor 1 expression in the pons of rats
M Martinez-Vargas et al.
NEUROSCIENCE (2003)
Pharmacokinetics and pharmacodynamics of cannabinoids
F Grotenhermen
CLINICAL PHARMACOKINETICS (2003)
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide
T Bisogno et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor
E Murillo-Rodríguez et al.
NEUROREPORT (2001)
分享论文
